We are live on
!
Find out more
NA
Nordwand Advisors Portfolio holdings
AUM
$652M
1-Year Est. Return
36.81%
This Fund
S&P 500
This Quarter
Est. Return
-4.32%
1 Year Est. Return
+36.81%
3 Year Est. Return
+92.97%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$505M
AUM Growth
-$78.7M
(-13%)
Cap. Flow
-$31.9M
Cap. Flow
% of AUM
-6.32%
Top 10 Holdings %
Top 10 Hldgs %
90.36%
Holding
130
New
11
Increased
7
Reduced
27
Closed
6
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
GSK
GSK
|
+$1.67M |
| 2 |
MDC
M.D.C. Holdings, Inc.
MDC
|
+$1.03M |
| 3 |
Devon Energy
DVN
|
+$1.02M |
| 4 |
IPVF
InterPrivate III Financial Partners Inc.
IPVF
|
+$561K |
| 5 |
Oaktree Specialty Lending
OCSL
|
+$437K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Berkshire Hathaway Class A
BRK.A
|
+$10.8M |
| 2 |
GUG
Guggenheim Active Allocation Fund
GUG
|
+$8.12M |
| 3 |
Reliance Steel & Aluminium
RS
|
+$3.3M |
| 4 |
Ferguson
FERG
|
+$2.29M |
| 5 |
Accenture
ACN
|
+$2.07M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 45.62% |
| 2 | Healthcare | 40.03% |
| 3 | Technology | 7.32% |
| 4 | Consumer Discretionary | 1.68% |
| 5 | Industrials | 1.5% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Berkshire Hathaway Class A
BRK.A
$1.08T
| $224M | 44.33% |
421
-20
| -5% | -$10.8M |
|
2
Johnson & Johnson
JNJ
$646B
| $167M | 33% |
1,069,569
-19
| -0% | -$3.13K |
|
3
NovoCure
NVCR
$2.08B
| $24.5M | 4.85% |
1,515,000
| – | – |
|
4
Microsoft
MSFT
$3.81T
| $11.7M | 2.32% |
37,101
-5,115
| -12% | -$1.69M |
|
5
Grab
GRAB
$14.8B
| $9.63M | 1.91% |
2,720,000
-200,000
| -7% | -$714K |
|
6
Apple
AAPL
$4.67T
| $4.59M | 0.91% |
26,791
-3,201
| -11% | -$587K |
|
7
Ardagh Metal Packaging
AMBP
$3.07B
| $4.51M | 0.89% |
1,439,893
+13,700
| +1% | +$48.2K |
|
8
MP Materials
MP
$10B
| $4.04M | 0.8% |
211,640
-24,980
| -11% | -$554K |
|
9
KB Financial Group
KB
$43.6B
| $3.44M | 0.68% |
83,652
-3,973
| -5% | -$157K |
|
|
MDC
10
DELISTED
M.D.C. Holdings, Inc.
MDC
| $3.39M | 0.67% |
82,254
+22,206
| +37% | +$1.03M |
|
11
Hubbell
HUBB
$24.3B
| $3.28M | 0.65% |
10,454
-1,836
| -15% | -$585K |
|
12
Intuit
INTU
$97.9B
| $3.23M | 0.64% |
6,321
-1,073
| -15% | -$543K |
|
13
UnitedHealth
UNH
$353B
| $3.21M | 0.64% |
6,375
-1,090
| -15% | -$536K |
|
|
14
Reliance Steel & Aluminium
RS
$19.8B
| $3.15M | 0.62% |
12,024
-11,911
| -50% | -$3.3M |
|
|
15
Devon Energy
DVN
$52.1B
| $3.12M | 0.62% |
65,396
+20,192
| +45% | +$1.02M |
|
16
AbbVie
ABBV
$451B
| $2.85M | 0.56% |
19,122
-3,283
| -15% | -$482K |
|
17
Broadcom
AVGO
$1.75T
| $2.66M | 0.53% |
32,060
-5,140
| -14% | -$446K |
|
18
Merck
MRK
$366B
| $2.56M | 0.51% |
24,859
-3,861
| -13% | -$416K |
|
19
Open Text
OTEX
$6.08B
| $2.49M | 0.49% |
70,985
-11,639
| -14% | -$456K |
|
|
20
Ferguson
FERG
$44.2B
| $2.42M | 0.48% |
14,723
-14,473
| -50% | -$2.29M |
|
21
TSMC
TSM
$2.17T
| $1.89M | 0.37% |
21,753
-3,473
| -14% | -$328K |
|
|
22
GSK
GSK
$102B
| $1.7M | 0.34% |
+47,019
| New | +$1.67M |
|
23
Equinor
EQNR
$98.2B
| $1.68M | 0.33% |
51,229
-3,177
| -6% | -$98.5K |
|
24
Coca-Cola
KO
$386B
| $1.42M | 0.28% |
25,336
-4,437
| -15% | -$266K |
|
25
Watsco Inc
WSO
$12.8B
| $1.3M | 0.26% |
3,443
-548
| -14% | -$198K |
|
Similar funds
TAWM
SCP
CFM
ESL
PPW
MW
WP
GWAG
Nordwand Advisors's Q3 2023 Portfolio in Review
As of Q3 2023, Nordwand Advisors held 130 positions worth $505M, down 13% from $583M the previous quarter. Its ten largest holdings account for 90% of the portfolio.
Nordwand Advisors withdrew a net $31.9M in Q3 2023, closing 6 positions and reducing 27 holdings. Its most notable exit was InterPrivate III Financial Partners Inc. Units, each consisting of one share of Class A common stock and one-fifth of one redeemable warrant, an estimated $563K position sold in full.
By sector, the portfolio is most concentrated in Financials at 46% of assets, up from 40% a quarter earlier, followed by Healthcare and Technology.
Against the trend, Nordwand Advisors opened a new position in GSK worth $1.7M.
- Nordwand Advisors's largest Q3 2023 buy was GSK: 47,019 shares worth $1.7M.
- Nordwand Advisors added most to M.D.C. Holdings, Inc. in Q3 2023, an estimated $1.03M increase.
- Nordwand Advisors's biggest Q3 2023 reduction was Berkshire Hathaway Class A, cutting an estimated $10.8M.
- Nordwand Advisors fully exited InterPrivate III Financial Partners Inc. Units, each consisting of one share of Class A common stock and one-fifth of one redeemable warrant in Q3 2023, selling an estimated $563K.
- Nordwand Advisors's ten largest holdings make up 90% of its $505M portfolio in Q3 2023.
- Nordwand Advisors opened 11 new positions and closed 6 in Q3 2023.
- Nordwand Advisors's portfolio value fell 13% quarter-over-quarter to $505M.
Based on Nordwand Advisors's 13F filing for Q3 2023, filed 27 Oct 2023.